Efficacy of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients : week-192 overall and subgroup analyses from STARTMRK
Mostra/ Apri
Data
2012Autore/i aziendale
Pontificia Universidad Javeriana. Facultad de Medicina. Departamento de Medicina Interna. Grupo de Investigación en Enfermedades Infecciosas HUSI - PUJ
Tipo
Artículo de revista
ISSN
1528-4336 / 1945-5771 (Electrónico)
Pagine
228-232
Tipo di oggetto
Reporte de caso
Condividi questo record
Citación
Metadata
Mostra tutti i dati dell'item
Documenti PDF
Astratto
We compared 4 years of antiretroviral therapy with tenofovir/emtricitabine and either raltegravir or efavirenz from the ongoing STARTMRK study of treatment-naïve HIV- infected patients. Through 192 weeks, raltegravir produced durable and consistent viral suppression and immune restoration compared with efavirenz irrespective of baseline demographic and prognostic factors, including in patients with high viral loads.
Editoriale
HIV Clinical Trials; Vol. 13 Núm. 4 (2012)
Google Analytics Statistics
Collections
- Artículos [164]